This sustained sell-off has wiped out approximately $18 billion in market capitalization, leaving its current value at around ...
The moves, to lower the cost of a drug prescribed to women going through IVF and boost employer coverage, follow Trump’s campaign promise to make fertility care more accessible.
The Trump administration has struck a deal with EMD Serono to lower drug prices — part of a larger push from the ...
President Donald Trump on Thursday announced a deal with EMD Serono, a subsidiary of German drugmaker Merck KGaA (XE:MRK) (MKKGY), that aims to cut the out-of-pocket costs for in vitro fertilization, ...
According to a Securities and Exchange Commission (SEC) filing dated October 16, 2025, ASSET PLANNING SERVICES INC /LA/ /ADV ...
After weeks of confusion, approval by CDC and its acting director mean most Nebraskans can get COVID-19 vaccines after consulting with a health care provider, including pharmacists.
OPKO Health, Inc. is refocusing on drug development, selling BioReference Lab assets to strengthen its balance sheet. Learn ...
Johnson & Johnson's Q3 2025 earnings beat forecasts, with strong oncology sales and raised guidance. Click for my updated ...
Zacks Investment Research on MSN
Protagonist Therapeutics Stock Gains 30% as J&J Reportedly Eyes Deal
Shares of Protagonist Therapeutics PTGX rose 30% on Friday following a report issued by the Wall Street Journal ("WSJ"), as ...
Shares of companies that make COVID-19 vaccines sank Friday, after a report raised fears that Trump administration health officials will blame the vaccines for some child deaths. The Washington Post ...
WASHINGTON (AP) — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to ...
President Donald Trump says “there seems to be no reason” to meet with Chinese leader Xi Jinping as part of an upcoming trip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results